Benefit-Risk Assessment of Medicines The Development and Application of a Universal Framework for Decision-Making and Effective Communication /

This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox. Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefi...

Full description

Bibliographic Details
Published in:Springer eBooks
Main Authors: Leong, James (Author), Salek, Sam (Author), Walker, Stuart (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Adis, 2015.
Subjects:
Online Access:http://dx.doi.org/10.1007/978-3-319-15805-1
Перейти в каталог НБ ТГУ
LEADER 03680nam a22004935i 4500
001 vtls000559100
003 RU-ToGU
005 20210922085915.0
007 cr nn 008mamaa
008 170212s2015 gw | s |||| 0|eng d
020 |a 9783319158051  |9 978-3-319-15805-1 
024 7 |a 10.1007/978-3-319-15805-1  |2 doi 
035 |a to000559100 
039 9 |y 201702122220  |z Александр Эльверович Гилязов 
040 |a Springer  |c Springer  |d RU-ToGU 
050 4 |a RS1-441 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 353.998  |2 23 
100 1 |a Leong, James.  |e author.  |9 465841 
245 1 0 |a Benefit-Risk Assessment of Medicines  |h electronic resource  |b The Development and Application of a Universal Framework for Decision-Making and Effective Communication /  |c by James Leong, Sam Salek, Stuart Walker. 
260 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2015.  |9 745061 
300 |a XIII, 317 p. 163 illus., 138 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Prologue -- Preface -- Overview -- Approaches to utilising decision-making framework -- Benefit-risk assessment of medicines by pharmaceutical companies and regulatory authorities -- Development of a universal benefit-risk framework and template -- Implementation of the benefit-risk assessment template by mature agencies -- Implementation of the benefit- risk summary template by a maturing agency: A case study -- Communicating benefit-risk decisions by US FDA, EMA, TGA and Health Canada -- Conclusions and future directions -- References. 
520 |a This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox. Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view to developing a structured, systematic, standardized approach. Examining the evaluation of such an approach by several mature regulatory authorities ensures that the reader gains a unique insight into the ongoing debate in this area. The field of benefit-risk assessment continues to evolve at a rapid pace due to political and societal pressure, as is reflected in the recent FDA PUDFA agreement as well as in the EMA 2015 Roadmap. Rather than provide a comprehensive snap-shot of this constantly changing environment, this book evaluates selected current approaches to benefit-risk assessment. The strengths and weaknesses of publicly available documents in communicating benefit-risk decisions to stakeholders are reviewed, and these evaluations are used to inform development of a prospective framework that could be used to harmonise procedures globally. 
650 0 |a medicine.  |9 566220 
650 0 |a Medical research.  |9 460787 
650 0 |a Pharmacy.  |9 299059 
650 0 |a quality of life.  |9 306168 
650 1 4 |a Medicine & Public Health.  |9 566221 
650 2 4 |a Drug Safety and Pharmacovigilance.  |9 447201 
650 2 4 |a Quality of Life Research.  |9 306170 
700 1 |a Salek, Sam.  |e author.  |9 465842 
700 1 |a Walker, Stuart.  |e author.  |9 465843 
710 2 |a SpringerLink (Online service)  |9 143950 
773 0 |t Springer eBooks 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-15805-1 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=414154 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650) 
999 |c 414154  |d 414154